ArticleInternational journal of molecular sciences2021

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.

Yann Grobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.